Sub-xiphoid hybrid maze for persistent atrial fibrillation after failed ablation
Part of Heart & circulation clinical trials.
This trial studies a hybrid heart procedure to treat persistent atrial fibrillation in people whose previous catheter ablation did not work. It aims to improve heart rhythm and reduce ongoing symptoms by using a planned combination of techniques and careful follow-up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 to 80 years old.
- You have persistent or longstanding persistent atrial fibrillation (not from a heart valve problem).
- You tried catheter ablation for atrial fibrillation before, and it failed.
- You can commit to follow-up visits and tests for at least 1 year, and you can sign consent.
- You cannot have had certain prior heart procedures that require opening the outer heart covering or entering the pericardial space.
- You must be well enough for the procedure (for example, no very severe heart failure symptoms and no major recent stroke/heart attack).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a catheter ablation procedure for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than 7 days but less than a year). It aims to see if the procedure is safe and effective for restoring a normal heart rhythm.
This study tests a new combination of treatments for people who have had atrial fibrillation (a type of irregular heartbeat) continuously for 1 to 3 years. The goal is to find a better way to restore normal heart rhythm and improve symptoms.
This study looks at what happens in the heart in people with persistent atrial fibrillation when they undergo an ablation or Maze surgery. It may help doctors better understand the condition and improve future care for people needing these procedures.
This trial compares two procedures to treat atrial fibrillation (an irregular heartbeat) in people who also have hypertrophic cardiomyopathy (thickened heart muscle). It looks at whether the hybrid approach or a catheter-based approach works better for controlling symptoms and heart rhythm.
This trial tests a new type of ablation (pulsed-field) to treat persistent atrial fibrillation (AFib) that lasts more than 7 days. You may qualify if you have symptoms and haven't had other heart ablation procedures except for one specific type.
This trial tests whether using a special heart-mapping device during ablation (a procedure to fix irregular heartbeats) can improve outcomes for people with persistent atrial fibrillation and an enlarged left heart chamber.
Hear when a new Atrial Fibrillation, Persistent trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.